Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-02-10
著者
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Takeuchi Kengo
Department Of Pathology Cancer Institute Japanese Foundation For Cancer Research
-
Takeuchi Kengo
Department Of Pathology The University Of Tokyo Hospital
-
MATSUO Keitaro
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
Kami Masahiro
Division Of Exploratory Research Institute Of Medical Science University Of Tokyo
-
Kami Masahiro
Jr東京総合病院 血液内科
-
HARA Shigeo
Department of Pathology, Toranomon Hospital
-
IWATA Hiroshi
Department of Cardiology, Toranomon Hospital
-
AOYAMA Tomonori
Department of Hematology, Toranomon Hospital
-
MURASHIGE Naoko
Hematopoietic Stem-cell Transplantation Unit, the National Cancer Center Hospital
-
KANDA Yoshinobu
Cell Therapy and Transplantation Medicine, the University of Tokyo Hospital
-
MORI Shin-ichiro
Department of Hematology, Tokyo Metropolitan Komagome Hospital
-
SUZUKI Risturo
Division of Molecular Medicine, Aichi Cancer Center Research Institute
-
TACHIBANA Shintaro
Department of Orthopedic Surgery, Toranomon Hospital
-
YAMANE Masaaki
Department of Otolaryngology, Toranomon Hospital
-
ODAWARA Masato
Department of Endocrinology and Metabolism, Toranomon Hospital
-
MUTOU Yoshitomo
Department of Hematology, Toranomon Hospital
-
KAMI Masahiro
Department of Hematology, Toranomon Hospital
-
Murashige Naoko
亀田メディカルセンター 腎臓高血圧内科
-
Murashige Naoko
Department Of Medical Oncology National Cancer Center Hospital
-
Murashige Naoko
Hematopoietic Stem Cell Transplantation Unit National Cancer Centre Hospital
-
Murashige Naoko
東京大学医科学研究所 探索医療ヒューマンネットワークシステム部門
-
Murashige Naoko
Department Of Medical Oncology The National Cancer Center Hospital
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
Matsue Kosei
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Matsuo Keitaro
Division Of Epidemiology And Prevention Aichi Cancer Center Research Institute
-
Matsuo Keitaro
国立がんセンター中央病院 造血幹細胞移植グループ
-
Matsuo Keitaro
虎の門病院(共済)
-
Suzuki R
Department Of Hsct Data Management Nagoya University Hospital
-
Suzuki Ritsurou
東京大学医学部附属病院 無菌治療部
-
Suzuki Ritsuro
豊橋市民病院 血液･腫瘍内科
-
Kaji Yoshikazu
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
MATSOU Keitaro
Second Department of Internal Medicine Okayama University Medical School
-
Miura Yuji
帝京大学ちば総合医療センター 内科(血液)
-
Hara Shigeo
Department Of Pathology Toranomon Hospital
-
Hara Shigeo
Department Of Materials Science & Technology Nagoya Institute Of Technology
-
Momomura Shin-ichi
Department Of Internal Medicine Miyazaki Prefectural Hospital
-
Shibata Taro
Department Of Obstetrics And Gynecology Kameda Medical Center
-
Kawakami M
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Kami Masahiro
Division Of Exploratory Research Institute Of Medical Science The University Of Tokyo
-
Kami Masahiro
Department Of Internal Medicine Toranomon Hospital
-
Suzuki Ritsurou
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Takeuchi Kengo
Department Of Laboratory Medicine Research Hospital The Institute Of Medical Science The University
-
Matsuo Keitaro
Division Of Epidemiology And Prevention Aichi Cancer Center
-
Yamane Masaaki
Department Of Otolaryngology Toranomon Hospital
-
Katayama Yoshio
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kanda Yoshinobu
Department Of Cell Therapy And Transplantation Medicine University Of Tokyo Hospital
-
Odawara Masato
Department Of Endocrinology And Metabolism Toranomon Hospital
-
Mutou Yoshitomo
Department Of Hematology And Department Of Nursing Toranomon Hospital
-
Kanda Yoshinobu
Cell Therapy And Transplantation Medicine The University Of Tokyo Hospital
-
Mizuno Shinichi
Department Of Internal Medicine Miyazaki Prefectural Hospital
-
Kaji Yoshikazu
First Department Of Internal Medicine Faculty Of Medicine Kyushu University
-
Mizuta Shuichi
Department Of Hematology Fujita Health University Hospital
-
Mori Shin-ichiro
Department Of Dental Radiology Fukuoka Dental College
-
Kami Masahiro
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Tachibana Shintaro
Department Of Orthopedic Surgery Toranomon Hospital
-
Suzuki Ritsuro
Department Of Hsct Data Management And Biostatistics Nagoya University School Of Medicine
-
Motoda Kinya
Division Of Epidemiology And Prevention Aichi Cancer Center
-
Komiyam Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Kashiwagi Yoichiro
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Masuoka Kazuhiro
Department Of Hematology Toranomon Hospital Kajigaya
-
Iwata Hiroshi
Department Of Cardiology Toranomon Hospital
-
Aoyama Tomonori
Department Of Electrical Engineering The University Of Tokyo
-
Aoyama Tomonori
Department Of Hematology Toranomon Hospital
-
Kaji Yoshikazu
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Odawara Masato
Department Of Diabetes Endocrinology And Metabolism Tokyo Medical University
-
Yamamoto K
Department Of Hematology And Oncology Graduate School Of Medicine University Of Tokyo
-
Kanemaru Misaki
Department Of Respiratory Medicine Allergy And Rheumatic Diseases Osaka University Graduate School Of Medicine
-
Suzuki Risturo
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Matsuo Keitaro
Division of Cardiology, Nippon Medical School
-
TACHIBANA Shintaro
Department of Orthopaedic Surgery, Toranomon Hospital
-
Aoyama Tomonori
Department of Chemistry, Faculty of Science & Technology, Keio University
-
HARA Shigeo
Department of Dairy Science, The College of Dairying
関連論文
- Why Do Japans Advanced Medical Treatments Never Get Ahead?
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
- Malignant change secondary to fibrous dysplasia
- Three cases with periosteal osteosarcoma arising from the femur
- Different Kinetics of WT1 and PML-RARα Gene Expression Levels during Remission Induction Therapy with All-trans Retinoic Acid Alone in Acute Promyelocytic Leukemia
- Effect of heparin addition on expansion of cord blood hematopoietic progenitor cells in three-dimensional coculture with stromal cells in nonwoven fabrics
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Lethal Adenovirus Infection in a Patient Who Had Undergone Nonmyeloblative Stem Cell Transplantation
- Soy consumption reduces the risk of non-small-cell lung cancers with epidermal growth factor receptor mutations among Japanese
- Meat, milk, saturated fatty acids, the Pro12Ala and C161T polymorphisms of the PPARγ gene and colorectal cancer risk in Japanese
- A polymorphism of C-to-T substitution at -31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population
- Dietary Risk Factors for Colon and Rectal Cancers : A Comparative Case-Control Study
- Effect of dietary antioxidants and risk of oral, pharyngeal and laryngeal squamous cell carcinoma according to smoking and drinking habits
- Significant association of interleukin 8-251T/A polymorphism with smoking behavior in a Japanese population
- Association between Smoking Habits and Dopamine Receptor D2 Taql A A2 Allele in Japanese Males : a Confirmatory Study
- A Limited Association of OGG1 Ser326Cys Polymorphism for Adenocarcinoma of the Lung
- Current status of development of anticancer agents in Japan
- Safety and usefulness of emergency maternal transport using helicopter
- Regional differences exist in allogeneic stem cell transplantation rates for acute leukemia
- Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients : possible involvement of graft-versus-host disease
- Graft-versus-Myeloma Effects in Reduced-Intensity Cord Blood Transplantation
- A study of cancer information for cancer patients on the internet
- Prevalence of Anemia among Healthy Women in 2 Metropolitan Areas of Japan
- Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies
- Increase Incidence of Lymphoid Malignancies in Patients Receiving Statins and Their Clinical Characteristics : A Case-Control Study Involving 1100 Patients
- A Prospective Surveillance of Nosocomial Respiratory Syncytial Virus Infection in a Hematology Ward: A Single-Center Experience in Japan
- Early Diagnosis of Central Nervous System Aspergillosis with Combination Use of Cerebral Diffusion-weighted Echo-planar Magnetic Resonance Image and Polymerase Chain Reaction of Cerebrospinal Fluid
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Protein Crystal Growth Using Laser-Processed Seed Crystals
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Allogeneic Peripheral Blood Stem Cell Transplantation in 23 Adult Patients With Hematologic Malignancies: A Single-Center Experience
- Granulocyte Colony-Stimulating Factor and Lineage-Independent Modulation of VLA-4 Expression on Circulating CD34^+ Cells
- Replating potential of colony-forming units of granulocytes/macrophages (CFE-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin
- Trisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia
- G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF
- Androgen therapy in combination with granulocyte colony-stimulating factor and erythropoietin in a patient with refractory anemia
- Predominant Infiltration of Monocytes in Chronic Graft-Versus-Host Disease
- The Lower Pole of the Earlobe is an Alternative Site for Painless Blood Sampling in the Self-assessment of Blood Glucose Concentrations
- Ischemic Colitis as a Manifestation of Thrombotic Microangiopathy Following Bone Marrow Transplantation
- The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
- Aldehyde Dehydrogenase 2 (ALDH2) Genotype Affects Rectal Cancer Susceptibility Due to Alcohol Consumption
- Alcohol, Smoking, and Dietary Status and Susceptibility to Malignant Lymphoma in Japan : Results of a Hospital-based Case-control Study at Aichi Cancer Center
- Smoking Habit and Interleukin 1B C-31T Polymorphism
- Possible Risk Reduction in Esophageal Cancer Associated with MPO -463 A allele
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
- Unmanipulated Reduced-Intensity Stem Cell Transplantation from a Haploidentical Donor Mismatched at 3 HLA Antigens to a Patient with Leukemic Transformation of Myelodysplastic Syndrome : Successful Second Transplantation after Graft Rejection
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
- Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
- Double High-dose Chemotherapy Supported by Autologous Transplantation of Peripheral Blood Stem Cells for Treatment of an Elderly Patient with Small-Cell Lung Cancer
- Imatinib mesylate inhibited rat adjuvant arthritis and PDGF-dependent growth of synovial fibroblast via interference with the Akt signaling pathway
- Preventative Effect of a Flavonoid, Enzymatically Modified Isoquercitrin on Ocular Symptoms of Japanese Cedar Pollinosis
- Prevalence of Epstein-Barr virus in Japan : Trends and future prediction
- Outcome of Involved-Field Radiotherapy for Stage 1 Follicular Lymphoma
- Immunological Reconstitution after Allogeneic and Autologous Bone Marrow Transplantation
- Peripheral T-cell Lymphoma of the Eyelid
- Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
- Mylotarg Is Not a "Magic Bullet"
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
- Autoimmune hemolytic anemia in allergic granulomatous angitis (Churg-Strauss syndrome)
- Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
- Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
- Long-term survival of soft tissue sarcoma patients with extrapulmonary metastasis
- WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
- Minimal influence of tocilizumab on IFN-γ synthesis by tuberculosis antigens
- Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation
- A case of Mikulicz's disease with Th2-biased cytokine profile : possible feature discriminable from Sjogren's syndrome
- Structural problems of medical news reports in newspapers : a verification of news reports on an incident of mass nosocomial Serratia infection
- Feasibility and Obstacles in Home Chemotherapy for Malignant Lymphoma
- AL amyloidosis with IgD-lambda monoclonal gammopathy and lambda-type Bence-Jones protein : successful treatment by autologous stem cell transplantation
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
- A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
- Contrast-enhanced endoscopic ultrasonography (CE-EUS) findings in adrenal metastasis from renal cell carcinoma
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab
- Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95